首页
热心肠日报
文献库
产业库
榜单
关于日报
《肠·道》演讲
往期精彩
《肠·道》2024
《肠·道》2023
《肠·道》2022
《肠·道》2021
《肠·道》2020
《肠·道》2019
《肠·道》2018
《肠·道》2017
关于《肠·道》
肠道大会
热心肠大会
热心肠智库
智库专家
专家动态
智库新闻
关于智库
奖学金
年度人物奖
更多
HOPE
会议信息
科学与艺术
学术专刊
R·AI
周刊
热心肠先生
研究院动态
关于我们
搜索
登录
关闭
手机邮箱登录
扫码登录
微信扫描二维码快捷登录
验证成功,将在
3
秒钟后跳转
已超时,请
重试
关闭
二维码登录
手机登录
邮箱登录
+86
+1
+852
+886
+81
+65
+61
+44
获取验证码
登录 / 注册
关闭
二维码登录
手机登录
邮箱登录
获取验证码
登录 / 注册
热心肠智库
专家文章 | 蔡军
2023
CA
Intensive Blood Pressure Lowering Improves Left Ventricular Hypertrophy in Older Patients with Hypertension: The STEP Trial
Hypertension, 10.1161/HYPERTENSIONAHA.122.20732
CA
Methodological and reporting quality of comprehensive hypertension guidelines published between 2017 and 2022
Chin Med J, 10.1097/CM9.0000000000002738
CA
Visit-to-Visit Blood Pressure Variability and Cardiovascular Outcomes in Patients Receiving Intensive Versus Standard Blood Pressure Control: Insights From the STEP Trial
Hypertension, 10.1161/HYPERTENSIONAHA.122.20376
CA
Achieved Systolic Blood Pressure and Cardiovascular Outcomes in 60-80-Year-Old Patients: The Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) Trial
EUR J PREV CARDIOL, 10.1093/eurjpc/zwad142
CA
The Influence of baseline glycemic status on the effects of intensive blood pressure lowering: Results from the STEP randomized trial
EUR J INTERN MED, 10.1016/j.ejim.2023.04.019
CA
Fecal microbiota transplantation: Emerging applications in autoimmune diseases
J Autoimmun, 10.1016/j.jaut.2023.103038
点击查看热心肠日报解读
CA
Intensive Blood Pressure Lowering and the Risk of New-onset Diabetes in Patients with Hypertension: A Post-hoc Analysis of the STEP Randomized Trial
EUR J PREV CARDIOL, 10.1093/eurjpc/zwad105
CA
Severity of non-alcoholic fatty liver disease is a risk factor for developing hypertension from prehypertension
Chin Med J, 10.1097/CM9.0000000000002111
CA
Single-cell transcriptome profiling reveals enriched memory T-cell subpopulations in hypertension
Front Cell Dev Biol, 10.3389/fcell.2023.1132040
CA
A Novel Symbiotic Formulation Reduces Obesity and Concomitant Metabolic Syndrome in Rats by Raising the Relative Abundance of Blautia
Nutrients, 10.3390/nu15040956
CA
Effects of intensive vs. standard blood pressure control on cognitive function: Post-hoc analysis of the STEP randomized controlled trial
FRONT NEUROL, 10.3389/fneur.2023.1042637
CA
Common or specific microbial features in Takayasu arteritis: Reply to the letter by Shirai et al
ARTHRITIS RHEUMATOL, 10.1002/art.42437
2022
CA
Effects of intensive blood pressure lowering in patients with diabetes: A pooled analysis of the STEP and ACCORD-BP randomized trials
DIABETES OBES METAB, 10.1111/dom.14927
CA
Kidney microbiota dysbiosis contributes to the development of hypertension
Gut Microbes, 10.1080/19490976.2022.2143220
点击查看热心肠日报解读
CA
Temporal Relationship Between Arterial Stiffness and Systolic Blood Pressure Under Intensive or Standard Control: A Post Hoc Analysis of the STEP Trial
Hypertension, 10.1161/HYPERTENSIONAHA.122.20022
CA
Influence of baseline arterial stiffness on effects of intensive compared with standard blood pressure control: a post hoc analysis of the STEP trial
BMC Med, 10.1186/s12916-022-02556-1
CA
Causality of Opportunistic Pathogen Klebsiella pneumoniae to Hypertension Development
Hypertension, 10.1161/HYPERTENSIONAHA.122.18878
点击查看热心肠日报解读
CA
Causality of Opportunistic Pathogen Klebsiella pneumoniae to Hypertension Development
Hypertension, 10.1161/HYPERTENSIONAHA.122.18878
点击查看热心肠日报解读
CA
Causality of Opportunistic Pathogen Klebsiella pneumoniae to Hypertension Development
Hypertension, 10.1161/HYPERTENSIONAHA.122.18878
CA
Causal associations between disorders of lipoprotein metabolism and ten cardiovascular diseases
Front Cell Dev Biol, 10.3389/fcell.2022.1023006